Anuh Pharma Limited (NSE:ANUHPHR)
India · Delayed Price · Currency is INR 81.94
-0.22 (-0.27%)
Nov 6, 2026, 3:29 PM IST
Anuh Pharma Market Cap
Anuh Pharma has a market cap or net worth of 8.28 billion as of November 6, 2026. Its market cap has decreased by 5.72% in one year.
Market Cap
8.28B
Enterprise Value
7.50B
Revenue
7.78B
Global Rank
n/a
Country Rank
n/a
PE Ratio
17.20
ChartMarket Cap Chart
Since January 2, 2008, Anuh Pharma's market cap has increased from 219.45M to 8.28B, an increase of 3,675.34%. That is a compound annual growth rate of 21.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 8.28B | 2.71% |
| Dec 31, 2025 | 8.07B | -28.75% |
| Dec 31, 2024 | 11.32B | 54.09% |
| Dec 29, 2023 | 7.35B | 64.17% |
| Dec 30, 2022 | 4.48B | -15.60% |
| Dec 31, 2021 | 5.30B | -22.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 30.04B |
| Sakar Healthcare | 21.48B |
| Windlas Biotech | 20.83B |
| Indoco Remedies | 19.69B |
| Beta Drugs | 18.66B |
| Anlon Healthcare | 14.88B |
| Jagsonpal Pharmaceuticals | 14.06B |
| Bafna Pharmaceuticals | 10.80B |